Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Northcott Neuroscience Laboratory, ANZAC Research Institute, University of Sydney, Concord, New South Wales, Australia.
Neurobiol Aging. 2021 Dec;108:200-206. doi: 10.1016/j.neurobiolaging.2021.07.008. Epub 2021 Jul 21.
Recent studies have identified SOD1, FUS, TARDBP and C9orf72 as major ALS-related genes in both European and Asian populations. However, significant differences exist in the mutation frequencies of these genes between various ancestral backgrounds. This study aims to identify the frequency of mutations in the common causative ALS genes in a multi-ethnic Malaysian cohort. We screened 101 Malaysian ALS patients including 3 familial and 98 sporadic cases for mutations in the coding regions of SOD1, FUS, and TARDBP by Sanger sequencing. The C9orf72 hexanucleotide repeat expansion was screened using the repeat-primed polymerase chain reaction assay. Mutations were found in 5.9% (6 of 101) of patients including 3.0% (3 of 101) of patients with the previously reported SOD1 missense mutations (p.V48A and p.N87S) and 3.0% (3 of 101) of patients with the C9orf72 repeat expansion. No mutations were found in the FUS and TARDBP genes. This study is the first to report the mutation frequency in an ethnically diverse Malaysian ALS population and warrants further investigation to reveal novel genes and disease pathways.
最近的研究已经确定 SOD1、FUS、TARDBP 和 C9orf72 是欧洲和亚洲人群中主要的 ALS 相关基因。然而,这些基因在不同祖先背景下的突变频率存在显著差异。本研究旨在确定在马来西亚多民族队列中常见的 ALS 致病基因的突变频率。我们通过 Sanger 测序筛选了 101 名马来西亚 ALS 患者(包括 3 个家族性和 98 个散发性病例)的 SOD1、FUS 和 TARDBP 编码区的突变。使用重复引物聚合酶链反应检测 C9orf72 六核苷酸重复扩增。在 5.9%(101 例患者中的 6 例)的患者中发现了突变,包括先前报道的 SOD1 错义突变(p.V48A 和 p.N87S)的 3.0%(101 例患者中的 3 例)和 C9orf72 重复扩增的 3.0%(101 例患者中的 3 例)。在 FUS 和 TARDBP 基因中未发现突变。本研究首次报道了在种族多样化的马来西亚 ALS 人群中的突变频率,需要进一步研究以揭示新的基因和疾病途径。